Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Test Uses Human Stem Cells to Identify Drug Side Effects

March 9, 2015 4:36 pm | by Sam Wong, Imperial College London | News | Comments

Scientists have developed a test that uses cells from a single donor's blood to predict whether a new drug will cause a severe reaction in humans. Read more...                 


Most Information in Drug Development is Lost

March 9, 2015 4:28 pm | by McGill University | News | Comments

Stalled drugs are drugs that fail to make it to the market either because they prove to be ineffective or unsafe or both. Read more...                     


Latin America IVD Market Exceeds $2B

March 9, 2015 4:16 pm | News | Comments

Latin America is a key target for IVD manufacturers seeking growth in testing revenues. Read more...                           


Vaccine Design Effective Against Herpes Viruses

March 9, 2015 10:29 am | News | Comments

Herpes simplex virus infections are an enormous global health problem and there is currently no viable vaccine. For nearly three decades, immunologists' efforts to develop a herpes vaccine have centered on exploiting a single protein found on the virus's outer surface that is known to elicit robust production of antibodies.  Read more...


Proposed Fund for 2012 Meningitis Victims Up to $210M

March 9, 2015 10:20 am | by Associated Press | News | Comments

A compensation fund for victims of a nationwide fungal meningitis outbreak blamed on a tainted steroid has grown to $210 million. Read more...                                    


Tiny Nanoparticles Could Make Impact for Cornea Transplant Patients

March 9, 2015 10:13 am | by Johns Hopkins | News | Comments

Animal study shows that a nanoparticle applied at the time of surgery slowly releases needed medicine to reduce risk of rejection after eye surgery. Read more...                                


Orexo U.S. Launches New Dosage of Opioid Dependence Drug

March 9, 2015 10:07 am | News | Comments

​Orexo US, Inc. (Orexo) announced that following U.S. Food and Drug Administration (FDA) approval, the new 8.6mg/2.1mg dosage strength of Zubsolv is now available.  Read more...


Stem Cell Researchers Develop Method to Treat Sickle Cell Disease

March 9, 2015 9:55 am | by UCLA | News | Comments

UCLA stem cell researchers have shown that a novel stem cell gene therapy method could lead to a one-time, lasting treatment for sickle cell disease—the nation's most common inherited blood disorder. Read more...


FDA Releases New Drug Shortages Mobile App

March 9, 2015 9:11 am | News | Comments

The app is available for iPhone and Android. Read more...                                  


Astellas Gains FDA Approval for Fungal Infection Treatment

March 9, 2015 8:39 am | News | Comments

The drug treats life-threatening fungal infections predominantly occurring in immunocompromised patients. Read more...                        


Spider Venom May Have Legs as Future Painkiller

March 9, 2015 8:26 am | by University of Queensland | News | Comments

This discovery could inspire a new class of potent painkillers with fewer side effects than current medications. Read more...                                     


Scientist Helps Develop New Tools to Probe Mysteries of the Brain

March 9, 2015 8:25 am | by University of Otago | News | Comments

An international collaboration developed new tools to probe cell types in the brain. Read more...                                             


Liberia Removes Ebola Crematorium as Outbreak is Contained

March 9, 2015 8:25 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

The cremations were very controversial because they were against traditional burial practices. Read more...                                            


Magnetic Material Attracts Attention for Cancer Therapy

March 9, 2015 8:24 am | by Monash University | News | Comments

An extraordinary self-regulating heating effect that can be achieved in a particular type of magnetic material may open the doors to a new strategy for hyperthermia cancer treatment. Read more...          


AbbVie to Buy Pharmacyclics for $21 Billion

March 6, 2015 3:18 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Investors did not seem pleased about this deal.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.